286 related articles for article (PubMed ID: 25052561)
1. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity.
Bishop AJ; Greenfield B; Mahajan A; Paulino AC; Okcu MF; Allen PK; Chintagumpala M; Kahalley LS; McAleer MF; McGovern SL; Whitehead WE; Grosshans DR
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):354-61. PubMed ID: 25052561
[TBL] [Abstract][Full Text] [Related]
2. A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications.
Lamiman K; Wong KK; Tamrazi B; Nosrati JD; Olch A; Chang EL; Kiehna EN
Neurosurg Focus; 2016 Dec; 41(6):E15. PubMed ID: 27903114
[TBL] [Abstract][Full Text] [Related]
3. Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma.
Greenfield BJ; Okcu MF; Baxter PA; Chintagumpala M; Teh BS; Dauser RC; Su J; Desai SS; Paulino AC
Radiother Oncol; 2015 Feb; 114(2):224-9. PubMed ID: 25542650
[TBL] [Abstract][Full Text] [Related]
4. Recurrent craniopharyngioma after conformal radiation in children and the burden of treatment.
Klimo P; Venable GT; Boop FA; Merchant TE
J Neurosurg Pediatr; 2015 May; 15(5):499-505. PubMed ID: 25700121
[TBL] [Abstract][Full Text] [Related]
5. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study.
Rutenberg MS; Rotondo RL; Rao D; Holtzman AL; Indelicato DJ; Huh S; Morris CG; Mendenhall WM
J Neurooncol; 2020 Apr; 147(2):387-395. PubMed ID: 32086697
[TBL] [Abstract][Full Text] [Related]
7. Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.
Xi M; Xu C; Liao Z; Chang JY; Gomez DR; Jeter M; Cox JD; Komaki R; Mehran R; Blum MA; Hofstetter WL; Maru DM; Bhutani MS; Lee JH; Weston B; Ajani JA; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):667-676. PubMed ID: 29280461
[TBL] [Abstract][Full Text] [Related]
8. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
[No Abstract] [Full Text] [Related]
9. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
[TBL] [Abstract][Full Text] [Related]
10. A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer.
Lukez A; Handorf E; Mendenhall NP; Henderson RH; Stish BJ; Davis BJ; Hallman M; Horwitz EM; Vapiwala N; Wong JK
Prostate; 2024 Mar; 84(4):395-402. PubMed ID: 38108113
[TBL] [Abstract][Full Text] [Related]
11. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.
Lin SH; Hobbs BP; Verma V; Tidwell RS; Smith GL; Lei X; Corsini EM; Mok I; Wei X; Yao L; Wang X; Komaki RU; Chang JY; Chun SG; Jeter MD; Swisher SG; Ajani JA; Blum-Murphy M; Vaporciyan AA; Mehran RJ; Koong AC; Gandhi SJ; Hofstetter WL; Hong TS; Delaney TF; Liao Z; Mohan R
J Clin Oncol; 2020 May; 38(14):1569-1579. PubMed ID: 32160096
[TBL] [Abstract][Full Text] [Related]
12. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
14. Exposure Risks Among Children Undergoing Radiation Therapy: Considerations in the Era of Image Guided Radiation Therapy.
Hess CB; Thompson HM; Benedict SH; Seibert JA; Wong K; Vaughan AT; Chen AM
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):978-92. PubMed ID: 27026304
[TBL] [Abstract][Full Text] [Related]
15. On the benefits and risks of proton therapy in pediatric craniopharyngioma.
Beltran C; Roca M; Merchant TE
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e281-7. PubMed ID: 21570209
[TBL] [Abstract][Full Text] [Related]
16. Proton Radiation Therapy for Pediatric Craniopharyngioma.
Jimenez RB; Ahmed S; Johnson A; Thomas H; Depauw N; Horick N; Tansky J; Evans CL; Pulsifer M; Ebb D; Butler WE; Fullerton B; Tarbell NJ; Yock TI; MacDonald SM
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1480-1487. PubMed ID: 33662460
[TBL] [Abstract][Full Text] [Related]
17. Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy.
Sato M; Gunther JR; Mahajan A; Jo E; Paulino AC; Adesina AM; Jones JY; Ketonen LM; Su JM; Okcu MF; Khatua S; Dauser RC; Whitehead WE; Weinberg J; Chintagumpala MM
Cancer; 2017 Jul; 123(13):2570-2578. PubMed ID: 28267208
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
[TBL] [Abstract][Full Text] [Related]
19. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.
Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N
Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899
[TBL] [Abstract][Full Text] [Related]
20. Comparison of multimodal surgical and radiation treatment methods for pediatric craniopharyngioma: long-term analysis of progression-free survival and morbidity.
Ravindra VM; Okcu MF; Ruggieri L; Frank TS; Paulino AC; McGovern SL; Horne VE; Dauser RC; Whitehead WE; Aldave G
J Neurosurg Pediatr; 2021 May; 28(2):152-159. PubMed ID: 34049281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
